BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 27022130)

  • 21. Ependymomas in Children and Adults.
    Lampros M; Vlachos N; Alexiou GA
    Adv Exp Med Biol; 2023; 1405():99-116. PubMed ID: 37452936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
    Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
    J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.
    Pajtler KW; Mack SC; Ramaswamy V; Smith CA; Witt H; Smith A; Hansford JR; von Hoff K; Wright KD; Hwang E; Frappaz D; Kanemura Y; Massimino M; Faure-Conter C; Modena P; Tabori U; Warren KE; Holland EC; Ichimura K; Giangaspero F; Castel D; von Deimling A; Kool M; Dirks PB; Grundy RG; Foreman NK; Gajjar A; Korshunov A; Finlay J; Gilbertson RJ; Ellison DW; Aldape KD; Merchant TE; Bouffet E; Pfister SM; Taylor MD
    Acta Neuropathol; 2017 Jan; 133(1):5-12. PubMed ID: 27858204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors.
    Ellison DW; Aldape KD; Capper D; Fouladi M; Gilbert MR; Gilbertson RJ; Hawkins C; Merchant TE; Pajtler K; Venneti S; Louis DN
    Brain Pathol; 2020 Sep; 30(5):863-866. PubMed ID: 32502305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.
    Shuangshoti S; Rushing EJ; Mena H; Olsen C; Sandberg GD
    Cancer; 2005 Jun; 103(12):2598-605. PubMed ID: 15861411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis by tumor location in adults with spinal ependymomas.
    Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT
    J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-grade ependymoma with late metastasis: autopsy case study and literature review.
    Alshaya W; Mehta V; Wilson BA; Chafe S; Aronyk KE; Lu JQ
    Childs Nerv Syst; 2015 Sep; 31(9):1565-72. PubMed ID: 25957762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B Fusion Negative Anaplastic Ependymoma with Lipogenic Differentiation.
    Jha S; Mulgulwar PB; Sharma MC; Purkait S; Pattnaik A; Sable MN
    Neurol India; 2023; 71(5):1011-1014. PubMed ID: 37929446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual paediatric spinal myxopapillary ependymomas: Unique molecular entities or pathological variations on a theme?
    Rogers S; Jones DTW; Ireland A; Gottardo NG; Endersby R
    J Clin Neurosci; 2018 Apr; 50():144-148. PubMed ID: 29402569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas.
    Tauziède-Espariat A; Nicaise Y; Sievers P; Sahm F; von Deimling A; Guillemot D; Pierron G; Duchesne M; Edjlali M; Dangouloff-Ros V; Boddaert N; Roux A; Dezamis E; Hasty L; Lhermitte B; Hirsch E; Hirsch MPV; Ardellier FD; Karnoub MA; Csanyi M; Maurage CA; Mokhtari K; Bielle F; Rigau V; Roujeau T; Abad M; Klein S; Bernier M; Horodyckid C; Adam C; Brandal P; Niehusmann P; Vannod-Michel Q; Provost C; de Champfleur NM; Nichelli L; Métais A; Mariet C; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2024 Apr; 12(1):55. PubMed ID: 38581034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling.
    Figarella-Branger D; Lechapt-Zalcman E; Tabouret E; Jünger S; de Paula AM; Bouvier C; Colin C; Jouvet A; Forest F; Andreiuolo F; Quintin-Roue I; Machet MC; Heitzmann A; Milin S; Sevestre H; Godfraind C; Labrousse F; Metellus P; Scavarda D; Pietsch T
    Neuro Oncol; 2016 Jul; 18(7):919-27. PubMed ID: 26984744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracranial ependymoma.
    Maksoud YA; Hahn YS; Engelhard HH
    Neurosurg Focus; 2002 Sep; 13(3):e4. PubMed ID: 15844876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of DNA Methylation Classification in Diagnosing Ependymoma.
    Abe E; Suzuki M; Ichimura K; Arakawa A; Satomi K; Ogino I; Hara T; Iwamuro H; Ohara Y; Kondo A
    World Neurosurg; 2024 May; 185():e1019-e1029. PubMed ID: 38479644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond.
    Kresbach C; Neyazi S; Schüller U
    Brain Pathol; 2022 Jul; 32(4):e13068. PubMed ID: 35307892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis by tumor location for pediatric spinal cord ependymomas.
    Oh MC; Sayegh ET; Safaee M; Sun MZ; Kaur G; Kim JM; Aranda D; Molinaro AM; Gupta N; Parsa AT
    J Neurosurg Pediatr; 2013 Mar; 11(3):282-8. PubMed ID: 23259510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin.
    Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Rajeshwari M; Singh M; Suri V; Sarkar C; Sharma MC
    J Neurooncol; 2018 May; 138(1):29-39. PubMed ID: 29354850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in Management of Pediatric Ependymomas.
    Lin FY; Chintagumpala M
    Curr Oncol Rep; 2015 Oct; 17(10):47. PubMed ID: 26369328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant behavior of myxopapillary ependymoma. Report of three cases.
    Davis C; Barnard RO
    J Neurosurg; 1985 Jun; 62(6):925-9. PubMed ID: 3998846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
    Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
    Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.